Literature DB >> 2827358

The diagnostic, prophylactic, and therapeutic uses of monoclonal antibodies to human cytomegalovirus.

D Emanuel1, J Peppard, J Chehimi, U Hammerling, R O'Reilly.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2827358

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

1.  Generation and application of a monoclonal antibody raised against a recombinant cytomegalovirus-specific polypeptide.

Authors:  G Jahn; H P Harthus; M Bröker; B Borisch; B Platzer; B Plachter
Journal:  Klin Wochenschr       Date:  1990-10-17

2.  Antibiotics enhance binding by human lipid A-reactive monoclonal antibody HA-1A to smooth gram-negative bacteria.

Authors:  S A Siegel; M E Evans; M Pollack; A O Leone; C S Kinney; S H Tam; P E Daddona
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

3.  [Diagnosis and clinical aspects of gastrointestinal cytomegalovirus diseases in patients with human immunodeficiency virus 1 infection].

Authors:  M Schrappe-Bächer; H M Steffen; G Ollenschläger; B Salzberger; G Fätkenheuer; S Degenhardt; G R Krüger
Journal:  Klin Wochenschr       Date:  1989-11-03

4.  Reactivity of the human antiendotoxin immunoglobulin M monoclonal antibody HA-1A with lipopolysaccharides from rough and smooth gram-negative organisms.

Authors:  M A Mascelli; B Frederick; T Ely; D S Neblock; D J Shealy; K Y Pak; P E Daddona
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

Review 5.  The use of immunoglobulin in bone marrow transplantation.

Authors:  P J Tutschka
Journal:  J Clin Immunol       Date:  1990-11       Impact factor: 8.317

6.  Molecular and Culture-Based Bronchoalveolar Lavage Fluid Testing for the Diagnosis of Cytomegalovirus Pneumonitis.

Authors:  Susanna K Tan; Elizabeth B Burgener; Jesse J Waggoner; Kiran Gajurel; Sarah Gonzalez; Sharon F Chen; Benjamin A Pinsky
Journal:  Open Forum Infect Dis       Date:  2016-02-10       Impact factor: 3.835

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.